(25S)-5alpha-cholestan-3beta,6alpha,7beta,8beta,15alpha,16beta,26-heptol

Metabolite details

Identifier

VHACFTUFOBCYNP-YDVWPAHASA-N

InChI Key

VHACFTUFOBCYNP-YDVWPAHASA-N

IUPAC name

(3S,5S,6R,7S,8S,9R,10S,13R,14S,15R,16R,17R)-17-[(2R,6S)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,6,7,8,15,16-hexol

Preferred name

(25S)-5alpha-cholestan-3beta,6alpha,7beta,8beta,15alpha,16beta,26-heptol

INN name

—

Synonym

—

ChEBI

CHEBI:184824

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• G1_PBS_vs_G2_DSS
• Control_vs_ZYP_High_Dose